Last edition
News about
Lincoln Pharmaceuticals Ltd Reports Net Profit of Rs. 27.65 Crore in Q2 FY24, 16.62% Y-o-Y
Lincoln Pharmaceuticals Limited has reported standalone net profit of Rs. 27.65 crore for the quarter ended 30th September 2023, growth of 16.62% Y-O-Y as compare to the net profit of Rs. 23.71 crore in Q2 FY23.
CPHI Barcelona: CMOs Account for 45 Percent Available Bio Capacity in 2027
The CPHI Annual Report predicts expected biologics demand and capacity for 2024-2027.
Berry Launches New Lightweight Tube Closure Solution
Berry Global has developed a lightweight tube closure solution that combines modern design and material versatility with a reduction of greenhouse gas emissions.
Snapdragon Chemistry Recognized with CPhI Pharma Award for API Development
The annual award is presented to a company that demonstrates innovation in technologies, products, processes and services for the development and manufacture of active pharmaceutical ingredients (APIs).
Leucine Bags USD 7 Mn To Make Pharma Manufacturing Safer With Its AI Tech Stack
The startup plans to utilise the funds to scale up its tech stack and refine its AI capabilities.
FDA Hits UCB Facility in Switzerland with Form 483, Cites Quality Control and Records Issues
UCB Farchim, a unit of Belgian drugmaker UCB, has been hit with a Form 483 from the FDA, with the observations mainly centered around quality control and record-keeping.
Strides Pharma to Sell its Singapore Manufacturing Facility for USD 15 million
Additionally, as part of the transaction, Rxilient Biohub will assume the long-term lease obligation associated with the manufacturing site from Strides.
Pharma.Aero's Green Air Pharma Lane Project Paving the Way for Sustainable Air Logistics
This pioneering endeavor, named the 'Green Air Pharma Logistics Project with a focus on a green lane,' is part of Pharma.Aero's broader initiative to promote environmental sustainability within the industry.
BASF Pharma Solutions Introduces VPA Premium Services
BASF Pharma Solutions expands its Virtual Pharma Assistants (VPA) platform by launching 'VPA Premium Services', a selection of new service options developed to meet customer demands for expanded access and content within the platforms.
Samsung Biologics and Kurma Partners Announce Strategic Partnership
Samsung Biologics and Kurma Partners have announced a strategic partnership for the development and manufacturing of biologics for Kurma Partners’ portfolio companies.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy